Apoptotic and proliferation indexes in primary superficial bladder tumors

Cancer Letters

Volumn 242, Issue 2, 2006, Pages 266-272

  Gonzalez Campora, Ricardo ^a   Davalos Casanova, Guillermo ^b   Beato Moreno, Antonio ^c   Luque, Rafael J ^d   Alvarez Kindelan, Jose ^e   Requena, Maria J ^e   Montironi, Rodolfo ^e   Lopez Beltrán, Antonio ^f  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b Department of Urology San Carlos Military Hospital ^*  (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d Pathology Department   (Spain)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Apoptosis; Bladder cancer; Ki 67

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ANALYTICAL PARAMETERS; APOPTOSIS; ARTICLE; BLADDER CARCINOGENESIS; BLADDER TUMOR; CANCER RISK; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; TUMOR RECURRENCE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; CELL PROLIFERATION; COHORT STUDIES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; URINARY BLADDER NEOPLASMS;

EID: 33749246362     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.11.006     Document Type: Article

References (28)

1. Jemal A., Tiwari R.C., Murray T., Ghafoor A., Samuels A., Ward E., et al. Cancer statistics 2005. CA Cancer J. Clin. 50 (2005) 10-30
2. Montironi R., Lopez-Beltran A., Mazzucchelli R., and Bostwick D.G. Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies. J. Clin. Pathol. 56 (2003) 91-95
3. Lee R., and Droller M.J. The natural history of bladder cancer: implications for therapy. Urol. Clin. North Am. 27 (2000) 1-13
4. Millán-Rodríguez F., Chechile-Toniolo G., Salvador-Bayarri J., Palou J., Algaba F., and Vicente-Rodriguez J. Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J. Urol. 164 (2000) 680-684
5. Amirghofran Z., Monabati A., Khezri A., and Malek-Hosseini Z. Apoptosis in transitional cell carcinoma of bladder and its relation to proliferation and expression of p53 and bcl-2. Pathol. Oncol. Res. 10 (2004) 154-158
6. Bol M.G.W., Baak J.P.A., van Diermen B., Buhr-Wildhagen S., Janssen E.A.M., Kjellevold K.H., et al. Proliferation markers and DNA content analysis in urinary bladder Ta-T1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks. J. Clin. Pathol. 56 (2003) 447-452
7. Cina S.J., Lancaster-Weiss K.J., Lecksel K., and Epstein J.I. Correlation of Ki-67 and p53 with the new world health organization/international society of urological pathology classification system for urothelial neoplasia. Arch. Pathol. Lab. Med. 125 (2001) 646-651
8. Dybowski B., Kupryjanczyk J., Rembiszewska A., Pykalo R., and BorKoski A. p27(Kip1) and Ki-67 expression analysis in transitional cell carcinoma of the bladder. Urol. Res. 31 (2003) 397-401
9. Fradet Y., and Lacombe L. Can biological markers predict recurrence and progression of superficial bladder cancer?. Curr. Opin. Urol. 10 (2000) 441-445
10. Liukkonen T., Rajala P., Raitanen M., Rintala E., Kaasinen E., and Lipponen P. Prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (stage pTa/T1) bladder cancer: a prospective comparative study. The Finnbladder Group. Eur. Urol. 36 (1999) 393-400
11. Lopez-Beltran A., Luque R.J., Alvarez-Kindelan J., Quintero A., Merlo F., Requena M.J., et al. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors. The role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Am. J. Clin. Pathol. 122 (2004) 444-452
12. Matsumoto H., Wada T., Fukunaga K., Yoshihiro S., Matsuyama H., and Naito K. Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer. Jpn. J. Clin. Oncol. 34 (2004) 124-130
13. Nakopoulou L., Vourlakou C., Zervas A., Tzonou A., Gakiopoulou H., and Dimopoulos M.A. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Hum. Pathol. 29 (1998) 146-154
14. Oosterhuis J.W., Schapers R.F., Janssen-Heijnen M.L., Smeets A.W., and Pauwels R.P. Mib-1 as a proliferative marker in transitional cell carcinoma of the bladder. Cancer 88 (2000) 2598-2605
15. Pich A., Chiusa L., Formiconi A., Galliano D., Bortolin P., Cominoi A., et al. Proliferative activity is the most significant predictor of recurrence in non-invasive papillary urothelial neoplasms of low malignant potential and grade 1 papillary carcinomas of the bladder. Cancer 95 (2002) 784-790
16. A. Quintero, J. Álvarez-Kindelan, R.J. Luque, R. González-Cámpora, M.J. Requena, R. Montironi, A. López-Beltrán, Ki-67-MIB1 labeling index and the prognosis of primary Ta-T1 urothelial cell carcinoma of the bladder, J. Clin. Pathol. 59 (2006) 83-88.
17. King E.D., Matteson J., Jacobs S.C., and Kyprianou N. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression. J. Urol. 155 (1996) 316-320
18. Vollmer R.T., Humphrey P.A., Swanson P.E., Wick M.R., and Hudson M.L. Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erb B-2, epidermal growth factor receptor, and bcl-2. Cancer 82 (1998) 715-723
19. Yan Y., Andriole G.L., Humphrey P.A., and Kibel A.S. Patterns of multiple recurrences of superficial (Ta/T1) transitional cell carcinoma of bladder and effects of clinicopathologic and biochemical factors. Cancer 95 (2002) 1239-1246
20. Zlotta A.R., Noel J.C., Fayt I., Drowart A., van Vooren J.P., Huygen K., et al. Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guérin intravesical therapy. J. Urol. 161 (1999) 792-798
21. Giannopoulou I., Nakapoulou L., Zervas A., Lazaris A.C., Stravodimos C., Giannopoulos A., et al. Immunohistochemical study of pro-apoptotic factors BAX, Fas and CPP32 in urinary bladder cancer: prognostic implication. Urol. Res. 30 (2002) 342-345
22. Korkolopoulou P., Lazaris A.C., Konstantinidou A.-E., Kavatzas N., Patsouris E., Christodoulou P., et al. Differential expression of bcl-2 family proteins in bladder carcinomas relationship with apoptotic rate and survival. Eur. Urol. 41 (2002) 274-283
23. Lara P.C., Pérez S., Rey A., and Santana C. Apoptosis in carcinoma of the bladder: relation with radiation treatment results. Int. J. Radiat. Oncol. Biol. Phys. 43 (1999) 1015-1019
24. Lipponen P.K., and Aaltomaa S S. Apoptosis in bladder cancer as related to standard prognostic factors and prognosis. J. Pathol. 173 (1994) 333-339
25. Matsumoto H., Wada T., Fukunaga K., Yoshihiro S., Matsuyama H., and Naito K. Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer. Jpn. J. Clin. Oncol. 34 (2004) 124-130
26. Moonen L., Ong F., Gallee M., Verheij M., Horenblas S., Hart A.A.M., et al. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) 1305-1310
27. Weiss C., Rödel F., Wolf I., Papadopoulos T., Engehausen D.G., Schrott K.M., et al. Combined-modality treatment and organ preservation in bladder cancer. Strahlenther. Onkol. 181 (2005) 213-222
28. Sauter G., Algaba F., Amin M.B., Busch C., Cheville J., Gasser T., et al. Non invasive urothelial tumors. In: Elbe J.N., Sauter G., Epstein J.I., and Sesterhenn I.A. (Eds). Pathology and Genetics. Tumors of the Urinary System and Male Genital Organs (2004), IARC Press, Lyon 110-111